Showing results (11-20 of 90) with videos related to

Sort By:
Pageof 9
Cancer Drug Resistance (Alhambra, Calif.)|May 18, 2022
Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancerPhilip C Miller, Dorraya El-Ashry, Marc E Lippman
Transactions of the American Clinical and Climatological Association|July 4, 2008
An expression signature of estrogen-regulated genes predicts disease-free survival in tamoxifen-treated patients better than progesterone receptor statusMarc E Lippman, James M Rae, Arul M Chinnaiyan
Frontiers in Bioscience (Landmark Edition)|May 31, 2011
Alternative splicing of RAGE: roles in biology and diseaseAnastasia Z Kalea, Ann Marie Schmidt, Barry I Hudson
Clinical Science (London, England : 1979)|March 12, 2009
RAGE: a novel biological and genetic marker for vascular diseaseAnastasia Z Kalea, Ann Marie Schmidt, Barry I Hudson
Molecular Cancer Therapeutics|March 16, 2021
Hormone-Dependent Prostate Cancers are Dependent on Rac Signaling for Growth and SurvivalErik T Goka, Dayrelis T Mesa Lopez, Marc E Lippman
Breast Cancer Research and Treatment|November 1, 2020
Spindle assembly checkpoint gene BUB1B is essential in breast cancer cell survivalDilara Koyuncu, Utsav Sharma, Erik T Goka, et al.
Molecular Cancer Therapeutics|May 7, 2020
Rac Signaling Drives Clear Cell Renal Carcinoma Tumor Growth by Priming the Tumor Microenvironment for an Angiogenic SwitchErik T Goka, Pallavi Chaturvedi, Dayrelis T Mesa Lopez, et al.
The Journal of Biological Chemistry|March 30, 2016
Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell FunctionAlex Braley, Taekyoung Kwak, Joel Jules, et al.
Psychoneuroendocrinology|February 21, 2021
Effects of brief stress management interventions on distress and leukocyte nuclear factor kappa B expression during primary treatment for breast cancer: A randomized trialAlain Diaz, Chloe J Taub, Marc E Lippman, et al.
Breast Cancer Research and Treatment|March 30, 2012
Mechanisms of estrogen-independent breast cancer growth driven by low estrogen concentrations are unique versus complete estrogen deprivationMatthew J Sikora, Viktoriya Strumba, Marc E Lippman, et al.
Pageof 9